72
Views
22
CrossRef citations to date
0
Altmetric
Special Report

Present and future control of cryptosporidiosis in humans and animals

Pages 669-671 | Published online: 09 Jan 2014

References

  • Ives NJ, Gazzard BG, Easterbrook PJ. Thechanging pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. .1. Infect. 42,134-139 (2001).
  • Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin. Microbiol. Rev. 15,145–154 (2002).
  • Widmer G, Carraway M, Tzipori S. Waterborne Cryptosporidiuni— a perspective from the USA. Parasitol. Today12, 286–290 (1996).
  • DuPont HL, Chappell CL, Sterling CR •et al. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl. Med. 332,855–859 (1995).
  • Jenkins M, Trout JM, Higgins J, Dorsch M, Veal D, Fayer R. Comparison of tests for viable and infectious Cryptosporidium parvum oocysts. Parasitol. Res. 89,1–5 (2003).
  • DeGraaf DC, Spano F, Petry F, Sagodira S, •Bonnin A. Speculation of whether a vaccine against cryptosporidiosis is a reality or fantasy. Intl J. Parasitol. 29,1289–1306 (1999).
  • Riggs MW Recent advances in ••cryptosporidiosis: the immune response. Microbes Infect. 4,1067–1080 (2002).
  • Schaefer DA, Auerbach-Dixon BA, Riggs MW Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis. Infect. Immun. 68, 2608–2616 (2000).
  • Perryman LE, Kapil SJ, Jones ML, Hunt EL. Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein. Vaccine 17, 2142–2149 (1999).
  • Jenkins MC, O'Brien C, Trout J, Guidry A, Fayer R. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice. Vaccine 17, 2453–2460 (1999).
  • He H, Zhao B, Liu L et al. The humoral and cellular immune responses in mice induced by DNA vaccine expressing the sporozoite surface protein of Cryptosporidium parvum. DNA Cell Biol. 23,335–339 (2004).
  • Jenkins M, Higgins J, Kniel K, Trout J, Fayer R. Protection of calves against cryptosporidiosis by oral inoculation with gamma-irradiated Cryptosporidium parvum oocysts. j Parasitol. 90,830–833 (2004).
  • Petri WA. Therapy of intestinal protozoa.•Trends Parasitol. 19,523–526 (2003).
  • White AC. Nitazoxanide: an important •advance in antiparasitic therapy. Am. J Trop. Med. Hyg. 68,82–283 (2003).
  • Mead JR. Cryptosporidiosis and the •challenges of chemotherapy. Drug Resist. Updates 5,47–57 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.